GLAXOSMITHKLINE PLC | CIK:0001131399 | 3

  • Filed: 3/20/2018
  • Entity registrant name: GLAXOSMITHKLINE PLC (CIK: 0001131399)
  • Generator: Donnelley Financial Solutions
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1131399/000119312518088407/0001193125-18-088407-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1131399/000119312518088407/gsk-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001131399
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory

    26. Assets held for sale

     

         2017      2016  
         £m      £m  

    Property, plant and equipment

         57        184  

    Goodwill

         —          13  

    Other intangibles

         49        12  

    Inventory

         7        7  

    Other

         —          (1
      

     

     

        

     

     

     
         113        215  
      

     

     

        

     

     

     

    Included within Assets held for sale is £31 million of intangible impairments, £10 million PP&E impairments, £21 million intangible impairment reversals and £15 million PP&E impairment reversals.

    Non-current assets and disposal groups are transferred to assets held for sale when it is expected that their carrying amounts will be recovered principally through disposal and a sale is considered highly probable. They are held at the lower of carrying amount and fair value less costs to sell.

    Included within Assets held for sale are assets which were written down to fair value less costs to sell of £63 million (2016 – £79 million). The valuation methodology uses significant inputs which are not based on observable market data, therefore, this valuation is classified as level 3 in the fair value hierarchy.